Complete Genomics Inc., a Mountain View, Calif.-based human genome sequencing company, has filed for an $86.25 million IPO. It plans to trade on the Nasdaq under ticker symbol GNOM, with UBS Investment Bank and Jefferies & Co. serving as co-lead underwriters.

The company has raised around $90 million in total VC funding since 2006, from Essex Woodlands Health Ventures, OrbiMed Advisors, Enterprise Partners Venture Capital, OVP Venture Partners, Prospect Venture Partners and Highland Capital Management. www.completegenomics.com

Related posts:

  1. Complete Genomics Raises $45 Million
  2. Complete Genomics’ Latest Financing “Very Difficult”
  3. Alimera Sciences Re-Files for IPO
  4. Ironwood Pharma Files for $172 Million IPO
  5. BG Medicine Re-Files for IPO